Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The rapid implementation of molecular HIV surveillance (MHS) has resulted in significant challenges for local health departments to develop real-time cluster detection and response (CDR) interventions for priority populations impacted by HIV. This study is among the first to explore professionals' strategies to implement MHS and develop CDR interventions in real-world public health settings. Methods: Semi-structured qualitative interviews were completed by 21 public health stakeholders in the United States' southern and midwestern regions throughout 2020-2022 to identify themes related to the implementation and development of MHS and CDR. Results for the thematic analysis revealed (1) strengths and limitations in utilizing HIV surveillance data for real-time CDR; (2) limitations of MHS data due to medical provider and staff concerns related to CDR; (3) divergent perspectives on the effectiveness of partner services; (4) optimism, but reluctance about the social network strategy; and (5) enhanced partnerships with community stakeholders to address MHS-related concerns. Conclusions: Enhancing MHS and CDR efforts requires a centralized system for staff to access public health data from multiple databases to develop CDR interventions; designating staff dedicated to CDR interventions; and establishing equitable meaningful partnerships with local community stakeholders to address MHS concerns and develop culturally informed CDR interventions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964218PMC
http://dx.doi.org/10.3390/ijerph20043269DOI Listing

Publication Analysis

Top Keywords

cdr interventions
20
hiv surveillance
12
public health
12
cdr
9
molecular hiv
8
develop real-time
8
real-time cluster
8
cluster detection
8
detection response
8
develop cdr
8

Similar Publications

Purpose This planning study aimed to clarify the significance of inverse planning with variable dose rate (VDR) and the segment shape optimization (SSO) in the quality and efficiency of dynamic conformal arcs (DCA) using the high-definition dynamic radiosurgery (HDRS) platform for stereotactic radiosurgery (SRS) of single brain metastases (BMs). Materials and methods Twenty clinical BMs were included, with the gross tumor volume (GTV) ranging from 0.33 cc to 48.

View Article and Find Full Text PDF

Purpose: This study aimed to investigate whether Jianpi-Zishen Formula (JPZS) modulates the Treg/Th17 balance in MRL/lpr mice through regulation of DNA methyltransferase 1 (DNMT1)-mediated forkhead box P3 (Foxp3) methylation, and to elucidate its potential mechanism for improving immune homeostasis in systemic lupus erythematosus (SLE).

Methods: Forty-eight female MRL/lpr mice were randomized into six groups (n=8/group): JPZS (low/medium/high doses), 5-aza-CdR (DNMT inhibitor), DC_517 (DNMT1 inhibitor), and model control. Eight C57BL/6 mice served as healthy controls.

View Article and Find Full Text PDF

Introduction: This study investigated evidence for or against a difference in treatment effect between women and men for lecanemab and donanemab.

Methods: Data were derived from supplementary analyses of the regulatory studies CLARITY-AD (lecanemab) and TRAILBLAZER-ALZ2 (donanemab). Bayes factor functions were used to analyze treatment effects on Clinical Dementia Rating Sum of Boxes (CDR-SB) scores.

View Article and Find Full Text PDF

Naturalistic driving behavior among older adults with and without epilepsy: A pilot study.

Epilepsy Behav

September 2025

Department of Neurology, Washington University School of Medicine, 660 Euclid Ave., Campus Box 8111, St. Louis, MO, USA; Institute of Public Health, Washington University in St. Louis, 600 S Taylor Ave, St. Louis, MO 63110, USA.

Objectives: Insufficient data exist for driving risk for people with epilepsy (PWE). This longitudinal, retrospective case-control study examines the differences in driving behaviors among older adults with/without epilepsy history using a novel naturalistic driving datalogger.

Methodology: Eligible participants were cognitively normal ([CDR] = 0) or had mild cognitive impairment (MCI) ([CDR] = 0.

View Article and Find Full Text PDF

Clinical progression on CDR-SB©: Progression-free time at each 0.5 unit level in dominantly inherited and sporadic Alzheimer's disease populations.

Alzheimers Dement

September 2025

Department of Psychiatry and The Behavioral Sciences, Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Introduction: Clinical Dementia Rating Sum of Boxes (CDR-SB) is a reliable and clinically meaningful composite for assessing treatment effects in Alzheimer's disease (AD) clinical trials. Small CDR-SB differences at the end of a trial often lead to controversy in deriving clinically meaningful interpretations.

Methods: We estimated progression-free time (PFT) participants remained at each 0.

View Article and Find Full Text PDF